Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Curr Pharm Biotechnol. 2016;17(9):772–787. doi: 10.2174/1389201017666160127110440

Fig. (7).

Fig. (7)

Porous MNs. (I) Images of MN integrated transdermal patch (MITP) during fabrication. (A) MNs with encapsulated rhodamine B. (B) A scanning electron microscope (SEM) image of single porous MN. (II) SEM of MITP before and after release test. MNs containing (A) 2.2 %, (B) 15 %, and (C) 21 % (w/w) lidocaine before release and (D), (E), and (F) after release, respectively. Copyright© with permission from 2013 American Chemical Society [93].